Literature DB >> 27794173

Vesicovaginal fistulas in the developed world: An analysis of disease characteristics, treatments, and complications of surgical repair using the ACS-NSQIP database.

Marissa C Theofanides1, Wilson Sui1, Elisabeth M Sebesta1, Ifeanyi Onyeji1, Justin T Matulay1, Doreen E Chung1.   

Abstract

AIMS: To analyze patient characteristics, complications, and surgical trends in vesicovaginal fistulas (VVF) from a national database.
METHODS: Current Procedural Terminology was used to identify patients undergoing VVF repair from the American College of Surgeons National Surgical Quality Improvement Project (NSQIP) database. Characteristics and treatments were identified. Logistic regression was used to identify characteristics associated with complications.
RESULTS: From 2006 to 2013, 200 patients underwent VVF repair. Mean age was 50.3 ± 12.3 years. A large proportion of patients were overweight (72%) and recent smokers (30%). Predominant comorbidities were heart disease (29%) and type 2 diabetes (9.5%). Of all VVF repairs, 65% were repaired vaginally. Concomitant procedures included hysterectomy (n = 6), reconstructive flaps (n = 13), and slings (n = 2). Post-operative complications occurred in 15% of patients. The most common complication was urinary tract infection (8%) followed by blood transfusion (3%). Compared to the vaginal approach, abdominal VVF repairs had higher overall morbidity (22% vs 7% P = 0.003), longer length of stay (3.5 ± 2.3 vs 1.6 ± 2 days P = 0.00) and were more likely to be associated with sepsis (4.3% vs 0% P = 0.02), blood transfusion (7.1% vs 0.8% P = 0.017), and readmission (10.1% vs 0.8% P = 0.003). In multivariate analysis, abdominal approach was a significant predictor of complications within 30 days (P = 0.03, P = 0.02).
CONCLUSIONS: In the US VVF remains a rare entity. Over half of VVFs were repaired vaginally. The occurrence of serious complications is low. A vaginal approach appears to be associated with fewer complications.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  demographics; developed countries; risk factors; trends; vesicovaginal fistula

Mesh:

Year:  2016        PMID: 27794173     DOI: 10.1002/nau.23167

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  2 in total

1.  [Prognostic factors for failure of transvaginal repair of vesicovaginal fistula: A nested case-control study].

Authors:  Y Yang; Y K Chen; X Y Che; S L Wu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-08-18

2.  The cost effectiveness of vaginal versus abdominal repair of vesicovaginal fistulae.

Authors:  Ross Warner; Alice Beardmore-Gray; Mahreen Pakzad; Rizwan Hamid; Jeremy Ockrim; Tamsin Greenwell
Journal:  Int Urogynecol J       Date:  2019-07-18       Impact factor: 2.894

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.